Published in J Am Soc Nephrol on February 01, 2004
Vascular access use and outcomes: an international perspective from the Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant (2008) 2.99
Predictors of delayed transition from central venous catheter use to permanent vascular access among ESRD patients. Am J Kidney Dis (2007) 2.39
Minocycline-EDTA lock solution prevents catheter-related bacteremia in hemodialysis. J Am Soc Nephrol (2011) 2.25
Associations between hemodialysis access type and clinical outcomes: a systematic review. J Am Soc Nephrol (2013) 2.22
Agreement of treatment effects for mortality from routinely collected data and subsequent randomized trials: meta-epidemiological survey. BMJ (2016) 2.12
Relationship between dialysis modality and mortality. J Am Soc Nephrol (2008) 2.06
Increased hemodialysis catheter use in Canada and associated mortality risk: data from the Canadian Organ Replacement Registry 2001-2004. Clin J Am Soc Nephrol (2008) 1.61
Cannulation technique influences arteriovenous fistula and graft survival. Kidney Int (2014) 1.41
Peritoneal-uterine communication: a complication of prolonged embedding of a peritoneal catheter. Perit Dial Int (2012) 1.38
Outcomes of arteriovenous fistula creation after the Fistula First Initiative. Clin J Am Soc Nephrol (2011) 1.25
Staphylococcus aureus bacteremia and buttonhole cannulation: long-term safety and efficacy of mupirocin prophylaxis. Clin J Am Soc Nephrol (2010) 1.13
Association of initial hemodialysis vascular access with patient-reported health status and quality of life. Clin J Am Soc Nephrol (2007) 1.09
Optimal hemodialysis vascular access in the elderly patient. Semin Dial (2012) 1.05
The organization and financing of dialysis and kidney transplantation services in New Zealand. Int J Health Care Finance Econ (2007) 1.02
Association of dialysis modality and cardiovascular mortality in incident dialysis patients. Clin J Am Soc Nephrol (2009) 1.01
The impact of an "acute dialysis start" on the mortality attributed to the use of central venous catheters: a retrospective cohort study. BMC Nephrol (2012) 0.99
Remote ischemic conditioning: from experimental observation to clinical application: report from the 8th Biennial Hatter Cardiovascular Institute Workshop. Basic Res Cardiol (2014) 0.98
Timing of arteriovenous fistula placement and Medicare costs during dialysis initiation. Am J Nephrol (2012) 0.95
Vascular access type, inflammatory markers, and mortality in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study. Am J Kidney Dis (2014) 0.94
Survival advantage of peritoneal dialysis relative to hemodialysis in the early period of incident dialysis patients: a nationwide prospective propensity-matched study in Korea. PLoS One (2013) 0.93
Association of Vascular Access Type with Mortality, Hospitalization, and Transfer to In-Center Hemodialysis in Patients Undergoing Home Hemodialysis. Clin J Am Soc Nephrol (2016) 0.93
Preventing AVF thrombosis: the rationale and design of the Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study. BMC Nephrol (2009) 0.91
Catheter-related mortality among ESRD patients. Semin Dial (2008) 0.91
Agreement of reported vascular access on the medical evidence report and on medicare claims at hemodialysis initiation. BMC Nephrol (2014) 0.87
Provider Visits and Early Vascular Access Placement in Maintenance Hemodialysis. J Am Soc Nephrol (2014) 0.87
Relation between access blood flow and mortality in chronic hemodialysis patients. Clin J Am Soc Nephrol (2008) 0.85
Should the arteriovenous fistula be created before starting dialysis?: a decision analytic approach. PLoS One (2011) 0.85
Superior patency of upper arm arteriovenous fistulae in high risk patients. J Surg Res (2011) 0.84
Provider visit frequency and vascular access interventions in hemodialysis. Clin J Am Soc Nephrol (2015) 0.84
Sociodemographic and geographic predictors of quality of care in United States patients with end-stage renal disease due to lupus nephritis. Arthritis Rheumatol (2015) 0.83
Role of far infra-red therapy in dialysis arterio-venous fistula maturation and survival: systematic review and meta-analysis. PLoS One (2014) 0.83
Randomised controlled trial to determine the appropriate time to initiate peritoneal dialysis after insertion of catheter to minimise complications (Timely PD study). BMC Nephrol (2010) 0.83
The transcription factor E26 transformation-specific sequence-1 mediates neointima formation in arteriovenous fistula. J Am Soc Nephrol (2013) 0.82
The Effect of Predialysis Fistula Attempt on Risk of All-Cause and Access-Related Death. J Am Soc Nephrol (2016) 0.82
The association between geographic proximity to a dialysis facility and use of dialysis catheters. BMC Nephrol (2014) 0.82
Comparison of quality-of-care measures in U.S. patients with end-stage renal disease secondary to lupus nephritis vs. other causes. BMC Nephrol (2015) 0.80
Hemodialysis versus Peritoneal Dialysis: A Comparison of Survival Outcomes in South-East Asian Patients with End-Stage Renal Disease. PLoS One (2015) 0.79
Predictive parameters of arteriovenous fistula functional maturation in a population of patients with end-stage renal disease. PLoS One (2015) 0.79
Honey in the Prevention and Treatment of Infection in the CKD Population: A Narrative Review. Evid Based Complement Alternat Med (2015) 0.79
Risk factors associated with hemodialysis central venous catheter malfunction; a retrospective analysis of a randomized controlled trial. Can J Kidney Health Dis (2014) 0.78
Predictors and outcomes of transfers from peritoneal dialysis to hemodialysis. Perit Dial Int (2014) 0.78
Status of initiating pattern of hemodialysis: a multi-center study. J Korean Med Sci (2009) 0.78
Rationale and design of the HEALTHY-CATH trial: a randomised controlled trial of Heparin versus EthAnol Lock THerapY for the prevention of Catheter Associated infecTion in Haemodialysis patients. BMC Nephrol (2009) 0.78
Patients started on hemodialysis with tunneled dialysis catheter have similar survival after arteriovenous fistula and arteriovenous graft creation. J Vasc Surg (2015) 0.78
Influence of vascular access type on sex and ethnicity-related mortality in hemodialysis-dependent patients. Perm J (2012) 0.78
The outcome of the primary vascular access and its translation into prevalent access use rates in chronic haemodialysis patients. Clin Kidney J (2012) 0.75
Laquinimod efficacy in relapsing-remitting multiple sclerosis: how to understand why and if studies disagree. BMC Neurol (2016) 0.75
Arteriovenous Grafts: Much Maligned But in Need of Reconsideration? Semin Dial (2017) 0.75
Comparison of vascular access outcomes in patients with end-stage renal disease attributed to systemic lupus erythematosus vs. other causes: a retrospective cohort study. BMC Nephrol (2016) 0.75
First year survival of patients on maintenance dialysis treatment in Poland. Nagoya J Med Sci (2015) 0.75
Comparison of treatment delay associated with tunneled hemodialysis catheter placement between interventionists. Korean J Intern Med (2016) 0.75
Vascular access and infection prevention and control: a national survey of routine practices in Irish haemodialysis units. Clin Kidney J (2013) 0.75
Offering Patients Therapy Options in Unplanned Start (OPTiONS): Implementation of an educational program is feasible and effective. BMC Nephrol (2017) 0.75
Tunnelled haemodialysis catheter and haemodialysis outcomes: a retrospective cohort study in Zagreb, Croatia. BMJ Open (2016) 0.75
The Type of Vascular Access and the Incidence of Mortality in Japanese Dialysis Patients. Intern Med (2017) 0.75
The impact of haemodialysis arteriovenous fistula on haemodynamic parameters of the cardiovascular system. Clin Kidney J (2016) 0.75
The Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study: the updated final trial protocol and rationale of post-initiation trial modifications. BMC Nephrol (2015) 0.75
Comparison of complications and dialysis adequacy between temporary and permanent tunnelled catheter for haemodialysis. Bosn J Basic Med Sci (2009) 0.75
Cancer incidence before and after kidney transplantation. JAMA (2006) 4.77
Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis (2008) 4.72
Prevalence of kidney damage in Australian adults: The AusDiab kidney study. J Am Soc Nephrol (2003) 4.15
Sulodexide for kidney protection in type 2 diabetes patients with microalbuminuria: a randomized controlled trial. Am J Kidney Dis (2011) 3.81
Diagnostic accuracy of urine dipsticks for detection of albuminuria in the general community. Am J Kidney Dis (2011) 3.29
The ultrafiltration coefficient of a dialyser (KUF) is not a fixed value, and it follows a parabolic function: the new concept of KUF max. Nephrol Dial Transplant (2010) 2.75
Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med (2002) 2.54
Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury. Kidney Int (2004) 2.29
Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice. J Am Soc Nephrol (2005) 2.23
Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy. Kidney Int (2010) 2.10
Indigenous people in Australia, Canada, New Zealand and the United States are less likely to receive renal transplantation. Kidney Int (2009) 1.96
Albuminuria is evident in the early stages of diabetes onset: results from the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Am J Kidney Dis (2004) 1.94
Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis (2004) 1.93
Phosphate binder use and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS): evaluation of possible confounding by nutritional status. Am J Kidney Dis (2012) 1.91
Staphylococcus aureus peritonitis in Australian peritoneal dialysis patients: predictors, treatment, and outcomes in 503 cases. Perit Dial Int (2010) 1.89
Reduction in cardiovascular death after kidney transplantation. Transplantation (2010) 1.89
Pyridorin in type 2 diabetic nephropathy. J Am Soc Nephrol (2011) 1.79
Smoking is associated with renal impairment and proteinuria in the normal population: the AusDiab kidney study. Australian Diabetes, Obesity and Lifestyle Study. Am J Kidney Dis (2002) 1.78
Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis (2004) 1.75
Secular trends in cardiovascular mortality rates of patients receiving dialysis compared with the general population. Am J Kidney Dis (2011) 1.71
ESRD in Australia and New Zealand at the end of the millennium: a report from the ANZDATA registry. Am J Kidney Dis (2002) 1.69
Associations of dialysis modality and infectious mortality in incident dialysis patients in Australia and New Zealand. Am J Kidney Dis (2008) 1.69
Corynebacterium peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 82 cases. Nephrol Dial Transplant (2009) 1.68
Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial. J Am Coll Cardiol (2006) 1.67
Home haemodialysis in Australia - is the wheel turning full circle? Med J Aust (2010) 1.67
Sulodexide fails to demonstrate renoprotection in overt type 2 diabetic nephropathy. J Am Soc Nephrol (2011) 1.66
Treatment of diffuse proliferative lupus nephritis: a meta-analysis of randomized controlled trials. Am J Kidney Dis (2004) 1.62
Improving CKD-MBD management in haemodialysis patients: barrier analysis for implementing better practice. Nephrol Dial Transplant (2010) 1.62
Peritoneal small solute clearance is nonlinearly related to patient survival in the Australian and New Zealand peritoneal dialysis patient populations. Perit Dial Int (2009) 1.61
Predictors of renal recovery in Australian and New Zealand end-stage renal failure patients treated with peritoneal dialysis. Perit Dial Int (2007) 1.59
Socioeconomic differences in the uptake of home dialysis. Clin J Am Soc Nephrol (2014) 1.57
Microbiology and outcomes of peritonitis in Australian peritoneal dialysis patients. Perit Dial Int (2011) 1.56
Transplantation rates for living- but not deceased-donor kidneys vary with socioeconomic status in Australia. Kidney Int (2012) 1.53
High membrane transport status on peritoneal dialysis is not associated with reduced survival following transfer to haemodialysis. Nephrol Dial Transplant (2007) 1.51
Macrophage accumulation in human progressive diabetic nephropathy. Nephrology (Carlton) (2006) 1.51
A single low-fixed dose of rituximab to salvage renal transplants from refractory antibody-mediated rejection. Transplantation (2009) 1.49
Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients. Kidney Int (2009) 1.49
The pattern of excess cancer in dialysis and transplantation. Nephrol Dial Transplant (2009) 1.48
Post-kidney transplant weight change as marker of poor survival outcomes. Transplantation (2008) 1.46
Encapsulating peritoneal sclerosis: incidence, predictors, and outcomes. Kidney Int (2010) 1.45
Untreated hypertension among Australian adults: the 1999-2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Med J Aust (2003) 1.44
Waiting time and outcome of kidney transplantation in adolescents. Transplantation (2006) 1.44
Prospective psychosocial monitoring of living kidney donors using the SF-36 health survey. Transplantation (2003) 1.44
Higher rate and earlier peritonitis in Aboriginal patients compared to non-Aboriginal patients with end-stage renal failure maintained on peritoneal dialysis in Australia: analysis of ANZDATA. Nephrology (Carlton) (2005) 1.43
Anorexia nervosa and senna misuse: nephrocalcinosis, digital clubbing and hypertrophic osteoarthropathy. Med J Aust (2008) 1.43
Native arteriovenous fistula blood flow and resistance during hemodialysis. Am J Kidney Dis (2003) 1.43
Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease. Nephrol Dial Transplant (2007) 1.42
Macrophages in streptozotocin-induced diabetic nephropathy: potential role in renal fibrosis. Nephrol Dial Transplant (2004) 1.42
Endothelial progenitor cells: novel biomarker and promising cell therapy for cardiovascular disease. Clin Sci (Lond) (2011) 1.41
Racial disparities in pediatric kidney transplantation in New Zealand. Pediatr Transplant (2014) 1.38
Atherosclerosis and folic acid supplementation trial in chronic renal failure: baseline results. Nephrology (Carlton) (2004) 1.38
Nonalbuminuric renal impairment in type 2 diabetic patients and in the general population (national evaluation of the frequency of renal impairment cO-existing with NIDDM [NEFRON] 11). Diabetes Care (2009) 1.37
Higher peritoneal transport status is associated with higher mortality and technique failure in the Australian and New Zealand peritoneal dialysis patient populations. J Am Soc Nephrol (2005) 1.37
Home hemodialysis and mortality risk in Australian and New Zealand populations. Am J Kidney Dis (2011) 1.37
Generation of induced pluripotent stem cells from human kidney mesangial cells. J Am Soc Nephrol (2011) 1.36
The role of macrophages in allograft rejection. Transplantation (2005) 1.32
Macrophages act as effectors of tissue damage in acute renal allograft rejection. Transplantation (2003) 1.32
Pseudomonas peritonitis in Australia: predictors, treatment, and outcomes in 191 cases. Clin J Am Soc Nephrol (2009) 1.31
Culture-negative peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes in 435 cases. Am J Kidney Dis (2010) 1.31
Adoptive transfer studies demonstrate that macrophages can induce proteinuria and mesangial cell proliferation. Kidney Int (2003) 1.30
Effects of body mass index at transplant on outcomes of kidney transplantation. Transplantation (2007) 1.26
Coagulase-negative staphylococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 936 cases. Nephrol Dial Transplant (2010) 1.24
Superior survival of high transporters treated with automated versus continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant (2010) 1.24
Health-related quality of life in Australian adults with renal insufficiency: a population-based study. Am J Kidney Dis (2003) 1.24
Remote indigenous peritoneal dialysis patients have higher risk of peritonitis, technique failure, all-cause and peritonitis-related mortality. Nephrol Dial Transplant (2011) 1.23
Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantation. Blood (2009) 1.23
Predictors, treatment, and outcomes of non-Pseudomonas Gram-negative peritonitis. Kidney Int (2010) 1.22
Randomized trial of darbepoetin alfa for treatment of renal anemia at a reduced dose frequency compared with rHuEPO in dialysis patients. Kidney Int (2002) 1.21
Association of carotid intima-medial thickness and indices of arterial stiffness with cardiovascular disease outcomes in CKD. Am J Kidney Dis (2007) 1.20
Lymphoproliferative disease after renal transplantation in Australia and New Zealand. Transplantation (2005) 1.20
Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study. BMJ (2010) 1.18
Epidemiology of diabetic nephropathy. Contrib Nephrol (2011) 1.18
Renal dialysis abatement: lessons from a social study. Palliat Med (2005) 1.17
Prevention of chronic kidney and vascular disease: toward global health equity--the Bellagio 2004 Declaration. Kidney Int Suppl (2005) 1.16
Streptococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 287 cases. BMC Nephrol (2009) 1.16
The directed differentiation of human iPS cells into kidney podocytes. PLoS One (2012) 1.15
Polymicrobial peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes. Am J Kidney Dis (2009) 1.15
Effect of a vascular access nurse coordinator to reduce central venous catheter use in incident hemodialysis patients: a quality improvement report. Am J Kidney Dis (2008) 1.15
Barriers to timely arteriovenous fistula creation: a study of providers and patients. Am J Kidney Dis (2011) 1.15
Blood pressure levels and mortality risk among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study. Kidney Int (2012) 1.15
Alcohol consumption and 5-year onset of chronic kidney disease: the AusDiab study. Nephrol Dial Transplant (2009) 1.14
Trends in hemodialysis vascular access from the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) 2000 to 2005. Am J Kidney Dis (2007) 1.14
A pathogenic role for c-Jun amino-terminal kinase signaling in renal fibrosis and tubular cell apoptosis. J Am Soc Nephrol (2007) 1.13
The role of p38alpha mitogen-activated protein kinase activation in renal fibrosis. J Am Soc Nephrol (2004) 1.12
Transition from pediatric to adult renal services: a consensus statement by the International Society of Nephrology (ISN) and the International Pediatric Nephrology Association (IPNA). Pediatr Nephrol (2011) 1.12
Limited knowledge of kidney disease in a survey of AusDiab study participants. Med J Aust (2008) 1.11
Recent peritonitis associates with mortality among patients treated with peritoneal dialysis. J Am Soc Nephrol (2012) 1.10
Maintenance treatment of renal anaemia in haemodialysis patients with methoxy polyethylene glycol-epoetin beta versus darbepoetin alfa administered monthly: a randomized comparative trial. Nephrol Dial Transplant (2010) 1.10
Albuminuria: marker or target in indigenous populations. Kidney Int Suppl (2004) 1.10